Cost–effectiveness analysis of endoscopic eradication therapy for treatment of high-grade dysplasia in Barrett’s esophagus
Author(s) -
Alex Filby,
Matthew H. Taylor,
Gideon Lipman,
Laurence Lovat,
Rehan Haidry
Publication year - 2017
Publication title -
journal of comparative effectiveness research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.567
H-Index - 23
eISSN - 2042-6313
pISSN - 2042-6305
DOI - 10.2217/cer-2016-0089
Subject(s) - medicine , barrett's esophagus , esophagus , radiofrequency ablation , dysplasia , cost effectiveness , cost effectiveness analysis , endoscopic mucosal resection , endoscopy , surgery , ablation , general surgery , cancer , adenocarcinoma , risk analysis (engineering)
The aim was to evaluate the cost-effectiveness of endoscopic eradication therapy (EET) with combined endoscopic mucosal resection and radiofrequency ablation for the treatment of high-grade dysplasia (HGD) arising in patients with Barrett's esophagus compared with endoscopic surveillance alone in the UK.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom